Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Net Cash Flow: 2019-2024

Historic Net Cash Flow for MDxHealth (MDXH) over the last 6 years, with Dec 2024 value amounting to $18.2 million.

  • MDxHealth's Net Cash Flow fell 112.19% to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year increase of 326.20%. This contributed to the annual value of $18.2 million for FY2024, which is 1684.74% up from last year.
  • According to the latest figures from FY2024, MDxHealth's Net Cash Flow is $18.2 million, which was up 1,684.74% from $1.0 million recorded in FY2023.
  • Over the past 5 years, MDxHealth's Net Cash Flow peaked at $38.8 million during FY2021, and registered a low of -$46.2 million during FY2022.
  • Moreover, its 3-year median value for Net Cash Flow was $1.0 million (2023), whereas its average is -$9.0 million.
  • In the last 5 years, MDxHealth's Net Cash Flow tumbled by 219.21% in 2022 and then surged by 1,684.74% in 2024.
  • MRY analysis of 5 years shows MDxHealth's Net Cash Flow stood at -$13.4 million in 2020, then skyrocketed by 389.99% to $38.8 million in 2021, then plummeted by 219.21% to -$46.2 million in 2022, then skyrocketed by 102.21% to $1.0 million in 2023, then soared by 1,684.74% to $18.2 million in 2024.
  • Its Net Cash Flow stands at $18.2 million for FY2024, versus $1.0 million for FY2023 and -$46.2 million for FY2022.